269.00 USD
↗ 14.81 (5.83%)AT CLOSE (03:59 PM EST)
Moderna, Inc. Common Stock
MRNANASDAQ • USD
271.38
↗ 2.38 (0.88%)
POST MARKET (AS OF 07:20 PM EST)
Post Market
AS OF 07:20 PM EST
271.38
↗ 2.38 (0.88%)
Market: OPEN
Moderna, Inc. Common Stock (MRNA) is currently trading at $271.38. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, MRNA is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 9, 2026.
Open?$257.86
High?$280.80
Low?$253.33
Prev. Close?$254.19
Volume?12.3M
Avg. Volume?17.5M
VWAP?$272.30
Rel. Volume?0.71x
Bid / Ask
Bid?$255.32 × 100
Ask?$282.81 × 100
Spread?$27.49
Midpoint?$269.07
Valuation & Ratios
Market Cap?101.5B
Shares Out?399.2M
Float?363.3M
Float %?91.0%
P/E Ratio?N/A
P/B Ratio?15.01
EPS?-$7.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Themes
Employees
4.7K
Market Cap
101.5B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-12-07
Address
325 BINNEY STREET
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?100
Momentum?10
Short Sent.?41
Piotroski F-Score?2/9Weak
Altman Z-Score?14.71Safe
Confidence?58%Low
Short InterestElevated
Short % of Float?8.97%Elevated
Short Interest?32.6M
Days to Cover?1.8
Free Float363.3M
Avg Daily Volume18.3M
Settlement Date2026-10-15
Financial Health
Current Ratio?2.29Strong
Quick Ratio?2.18Strong
Cash Ratio?0.68Adequate
Debt/Equity?0.09Low
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?15.01HIGH▾
Peers33
S&P12
P/S?45.55HIGH▾
Peers27
S&P3
P/FCF?N/A▾
EV/EBITDA?-32.6CHEAP▾
Peers100
S&P97
EV/Sales?45.04HIGH▾
Peers27
S&P3
Returns & Efficiency
ROE?-46.6%WEAK▾
Peers10
S&P3
ROA?-28.7%WEAK▾
Peers13
S&P3
Cash Flow & Enterprise
FCF?$-1244000000
Enterprise Value?$100.4B
Fundamentals ratios updated end of day